Lars Jorgensen
Lars Jorgensen is the CEO of Novo Nordisk, a leading global healthcare company based in Denmark, known for its innovative diabetes and obesity treatments. Under his leadership, the company announced a significant investment of R$ 6.4 billion to expand its manufacturing facility in Montes Claros, Brazil, highlighting the strategic importance of the Brazilian market for Novo Nordisk.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.07% | +0% | 8,654,622 | 5,638 | $700,000 | 456$ |
| Totals | 1 | 8,654,622 | 5,638 | $700,000 | 456$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Lars Jörgensen is the CEO of Novo Nordisk, who is set to leave his position before the end of his term.
5
Liechtenstein:
Lars Jorgensen is the CEO of Novo Nordisk and announced a significant investment in Brazil.
9